PAK5
Basic information
Region (hg38): 20:9537370-9839076
Previous symbols: [ "PAK7" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PAK5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 33 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 1 | 5 |
Variants in PAK5
This is a list of pathogenic ClinVar variants found in the PAK5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-9539494-C-T | not specified | Uncertain significance (Apr 20, 2024) | ||
20-9539525-G-C | not specified | Uncertain significance (Oct 05, 2023) | ||
20-9539575-T-C | not specified | Uncertain significance (Dec 17, 2023) | ||
20-9542639-C-A | not specified | Uncertain significance (Dec 14, 2023) | ||
20-9542694-C-T | not specified | Uncertain significance (Aug 02, 2022) | ||
20-9542717-C-A | not specified | Uncertain significance (May 04, 2022) | ||
20-9544431-A-G | Benign (Jul 15, 2018) | |||
20-9565907-G-A | Benign (Apr 12, 2022) | |||
20-9566030-A-T | not specified | Uncertain significance (Mar 02, 2023) | ||
20-9566114-C-A | not specified | Uncertain significance (Jul 20, 2021) | ||
20-9566203-C-T | not specified | Uncertain significance (May 16, 2023) | ||
20-9566230-A-G | not specified | Uncertain significance (Aug 30, 2022) | ||
20-9566236-G-C | not specified | Uncertain significance (Sep 26, 2023) | ||
20-9566303-G-A | not specified | Uncertain significance (Jul 20, 2022) | ||
20-9566318-C-G | not specified | Uncertain significance (May 30, 2023) | ||
20-9566318-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
20-9566375-C-T | not specified | Uncertain significance (Jan 17, 2023) | ||
20-9566376-G-A | Benign (Dec 31, 2019) | |||
20-9580150-G-T | not specified | Uncertain significance (Apr 06, 2022) | ||
20-9580167-T-C | not specified | Uncertain significance (Oct 27, 2022) | ||
20-9580251-G-A | not specified | Uncertain significance (Nov 23, 2022) | ||
20-9580280-C-A | not specified | Uncertain significance (Dec 13, 2023) | ||
20-9580287-C-A | not specified | Uncertain significance (Aug 04, 2023) | ||
20-9580314-T-C | not specified | Uncertain significance (Dec 14, 2023) | ||
20-9580380-T-A | not specified | Uncertain significance (Nov 09, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PAK5 | protein_coding | protein_coding | ENST00000378429 | 8 | 301654 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000228 | 125724 | 0 | 24 | 125748 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.47 | 329 | 413 | 0.796 | 0.0000239 | 4727 |
Missense in Polyphen | 151 | 230.67 | 0.65461 | 2605 | ||
Synonymous | 0.391 | 168 | 175 | 0.962 | 0.0000120 | 1400 |
Loss of Function | 4.76 | 1 | 28.4 | 0.0352 | 0.00000128 | 356 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000906 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00217 | 0.000416 |
European (Non-Finnish) | 0.000414 | 0.000105 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000979 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell migration, proliferation or cell survival. Activation by various effectors including growth factor receptors or active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Phosphorylates the proto-oncogene RAF1 and stimulates its kinase activity. Promotes cell survival by phosphorylating the BCL2 antagonist of cell death BAD. Phosphorylates CTNND1, probably to regulate cytoskeletal organization and cell morphology. Keeps microtubules stable through MARK2 inhibition and destabilizes the F-actin network leading to the disappearance of stress fibers and focal adhesions. {ECO:0000269|PubMed:12897128, ECO:0000269|PubMed:16014608, ECO:0000269|PubMed:16581795, ECO:0000269|PubMed:18465753, ECO:0000269|PubMed:20564219}.;
- Pathway
- Focal adhesion - Homo sapiens (human);T cell receptor signaling pathway - Homo sapiens (human);Renal cell carcinoma - Homo sapiens (human);ErbB signaling pathway - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Axon guidance - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);MET in type 1 papillary renal cell carcinoma;Ras Signaling;Regulation of Actin Cytoskeleton;Developmental Biology;Activation of RAC1;IL-7 signaling;agrin in postsynaptic differentiation;JAK STAT pathway and regulation;EPO signaling;Signaling by ROBO receptors;Axon guidance;VEGF
(Consensus)
Recessive Scores
- pRec
- 0.233
Intolerance Scores
- loftool
- rvis_EVS
- -0.22
- rvis_percentile_EVS
- 37.6
Haploinsufficiency Scores
- pHI
- 0.424
- hipred
- Y
- hipred_score
- 0.819
- ghis
- 0.568
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Pak7
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of cell growth;apoptotic process;cytoskeleton organization;signal transduction;learning;memory;locomotory behavior;cell population proliferation;cell migration;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;regulation of MAPK cascade;negative regulation of extrinsic apoptotic signaling pathway
- Cellular component
- nucleoplasm;cytoplasm;mitochondrion;synapse
- Molecular function
- protein serine/threonine kinase activity;protein binding;ATP binding;Rac GTPase binding